| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Primary Ovarian Insufficiency | 8 | 2015 | 50 | 1.620 |
Why?
|
| Infertility, Female | 2 | 2015 | 145 | 0.820 |
Why?
|
| Hyaluronic Acid | 3 | 2019 | 107 | 0.620 |
Why?
|
| Intrauterine Devices | 1 | 2019 | 13 | 0.580 |
Why?
|
| Viscosupplements | 1 | 2019 | 8 | 0.580 |
Why?
|
| Tissue Adhesions | 1 | 2019 | 26 | 0.570 |
Why?
|
| Spermatozoa | 7 | 2009 | 254 | 0.520 |
Why?
|
| Ovarian Follicle | 2 | 2015 | 127 | 0.440 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2015 | 69 | 0.430 |
Why?
|
| Fragile X Syndrome | 1 | 2015 | 148 | 0.410 |
Why?
|
| Pregnancy | 21 | 2022 | 7512 | 0.400 |
Why?
|
| Decidua | 6 | 2017 | 143 | 0.390 |
Why?
|
| Stromal Cells | 6 | 2017 | 316 | 0.370 |
Why?
|
| Hormone Replacement Therapy | 1 | 2015 | 187 | 0.370 |
Why?
|
| Estrogens | 1 | 2015 | 434 | 0.360 |
Why?
|
| Oligospermia | 5 | 2005 | 65 | 0.360 |
Why?
|
| Endometrium | 4 | 2019 | 292 | 0.320 |
Why?
|
| Anti-Mullerian Hormone | 2 | 2023 | 46 | 0.300 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2022 | 3436 | 0.300 |
Why?
|
| Diploidy | 3 | 2005 | 40 | 0.300 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2007 | 288 | 0.290 |
Why?
|
| Semen | 2 | 2004 | 84 | 0.240 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2009 | 289 | 0.240 |
Why?
|
| Oocytes | 1 | 2007 | 283 | 0.230 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2015 | 2833 | 0.230 |
Why?
|
| Aneuploidy | 2 | 2005 | 138 | 0.220 |
Why?
|
| Sperm Count | 2 | 2004 | 100 | 0.220 |
Why?
|
| Phenylmethylsulfonyl Fluoride | 1 | 2004 | 1 | 0.210 |
Why?
|
| Semen Preservation | 1 | 2004 | 16 | 0.210 |
Why?
|
| Uniparental Disomy | 2 | 2005 | 42 | 0.210 |
Why?
|
| Cytoplasm | 2 | 2004 | 249 | 0.210 |
Why?
|
| Blood Pressure | 1 | 2010 | 1345 | 0.200 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2005 | 743 | 0.200 |
Why?
|
| Ovarian Reserve | 1 | 2023 | 15 | 0.200 |
Why?
|
| Progesterone | 3 | 2022 | 439 | 0.200 |
Why?
|
| Abortion, Spontaneous | 2 | 2014 | 81 | 0.190 |
Why?
|
| Receptors, Progesterone | 3 | 2015 | 677 | 0.190 |
Why?
|
| Nuclear Receptor Coactivator 2 | 2 | 2014 | 147 | 0.190 |
Why?
|
| Female | 39 | 2023 | 70963 | 0.180 |
Why?
|
| Doxorubicin | 1 | 2023 | 288 | 0.180 |
Why?
|
| Multifactorial Inheritance | 1 | 2022 | 176 | 0.170 |
Why?
|
| Chromatin | 1 | 2004 | 499 | 0.160 |
Why?
|
| Adult | 24 | 2023 | 31282 | 0.160 |
Why?
|
| Chromosome Aberrations | 1 | 2003 | 573 | 0.160 |
Why?
|
| WNK Lysine-Deficient Protein Kinase 1 | 2 | 2017 | 14 | 0.160 |
Why?
|
| Humans | 46 | 2023 | 131163 | 0.150 |
Why?
|
| Sperm Injections, Intracytoplasmic | 3 | 2005 | 51 | 0.150 |
Why?
|
| Hysteroscopy | 1 | 2019 | 13 | 0.140 |
Why?
|
| Gels | 1 | 2019 | 59 | 0.140 |
Why?
|
| Leiomyoma | 2 | 2009 | 71 | 0.140 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2015 | 175 | 0.130 |
Why?
|
| Gestational Age | 6 | 2010 | 1224 | 0.130 |
Why?
|
| Cell Differentiation | 3 | 2014 | 1928 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2017 | 11 | 0.130 |
Why?
|
| Secondary Prevention | 1 | 2019 | 217 | 0.130 |
Why?
|
| Risk Assessment | 1 | 2006 | 3711 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2014 | 86 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1336 | 0.120 |
Why?
|
| Mass Screening | 1 | 2022 | 822 | 0.120 |
Why?
|
| Ultrasonography | 3 | 2019 | 943 | 0.120 |
Why?
|
| Down Syndrome | 4 | 1999 | 233 | 0.110 |
Why?
|
| ADAMTS Proteins | 1 | 2015 | 10 | 0.110 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2015 | 10 | 0.110 |
Why?
|
| Oocyte Donation | 1 | 2015 | 5 | 0.110 |
Why?
|
| Embryo Implantation | 2 | 2013 | 218 | 0.110 |
Why?
|
| Inhibins | 1 | 2015 | 82 | 0.110 |
Why?
|
| ADAM Proteins | 1 | 2015 | 78 | 0.110 |
Why?
|
| Interferon Regulatory Factors | 1 | 2015 | 46 | 0.110 |
Why?
|
| Embryo, Mammalian | 3 | 2022 | 403 | 0.110 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2015 | 67 | 0.110 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 3 | 1999 | 27 | 0.110 |
Why?
|
| Infertility | 1 | 2015 | 76 | 0.110 |
Why?
|
| Genome-Wide Association Study | 3 | 2022 | 1833 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2014 | 992 | 0.100 |
Why?
|
| Osteoporosis | 1 | 2015 | 133 | 0.100 |
Why?
|
| Phosphofructokinase-2 | 1 | 2013 | 22 | 0.100 |
Why?
|
| X Chromosome | 2 | 2007 | 327 | 0.100 |
Why?
|
| Activin Receptors, Type I | 1 | 2013 | 34 | 0.100 |
Why?
|
| Pilot Projects | 3 | 2022 | 1445 | 0.100 |
Why?
|
| RNA, Small Interfering | 4 | 2017 | 664 | 0.100 |
Why?
|
| Gene Expression | 2 | 2010 | 1481 | 0.100 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 1363 | 0.100 |
Why?
|
| Uterus | 2 | 2014 | 541 | 0.090 |
Why?
|
| Endometriosis | 2 | 2014 | 176 | 0.090 |
Why?
|
| Cell Proliferation | 3 | 2017 | 2465 | 0.090 |
Why?
|
| ErbB Receptors | 1 | 2014 | 286 | 0.090 |
Why?
|
| DNA Probes | 2 | 2003 | 117 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 371 | 0.090 |
Why?
|
| Fertility | 1 | 2014 | 260 | 0.090 |
Why?
|
| Fertilization in Vitro | 2 | 2004 | 155 | 0.090 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2012 | 161 | 0.090 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2002 | 72 | 0.090 |
Why?
|
| Ultrasonography, Prenatal | 4 | 2002 | 986 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 2602 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 318 | 0.080 |
Why?
|
| DNA Mutational Analysis | 3 | 2007 | 775 | 0.080 |
Why?
|
| Estriol | 3 | 1999 | 12 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 15 | 2 | 2007 | 44 | 0.080 |
Why?
|
| Growth Differentiation Factor 9 | 2 | 2007 | 50 | 0.080 |
Why?
|
| Prognosis | 3 | 2015 | 4886 | 0.080 |
Why?
|
| Mexico | 1 | 2010 | 190 | 0.070 |
Why?
|
| Relaxin | 1 | 2009 | 16 | 0.070 |
Why?
|
| Mutation | 3 | 2007 | 6099 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 567 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2015 | 1717 | 0.070 |
Why?
|
| Biomarkers | 3 | 2015 | 3385 | 0.070 |
Why?
|
| Uterine Neoplasms | 1 | 2009 | 100 | 0.070 |
Why?
|
| Neck | 2 | 1999 | 140 | 0.070 |
Why?
|
| alpha-Fetoproteins | 2 | 1998 | 125 | 0.070 |
Why?
|
| Chromosome Deletion | 1 | 2011 | 653 | 0.070 |
Why?
|
| Gene Dosage | 1 | 2009 | 435 | 0.070 |
Why?
|
| Sex Determination Processes | 1 | 2007 | 11 | 0.070 |
Why?
|
| Young Adult | 4 | 2023 | 10103 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2006 | 242 | 0.060 |
Why?
|
| Y Chromosome | 2 | 2007 | 47 | 0.060 |
Why?
|
| Pregnancy Rate | 2 | 2022 | 40 | 0.060 |
Why?
|
| Embryo Transfer | 2 | 2022 | 48 | 0.060 |
Why?
|
| Disease Progression | 1 | 2012 | 2200 | 0.060 |
Why?
|
| Prenatal Diagnosis | 3 | 1999 | 612 | 0.060 |
Why?
|
| Anemia | 2 | 2000 | 354 | 0.060 |
Why?
|
| Sperm Maturation | 2 | 2009 | 15 | 0.060 |
Why?
|
| Uterine Perforation | 1 | 2004 | 2 | 0.050 |
Why?
|
| Hysterosalpingography | 1 | 2004 | 6 | 0.050 |
Why?
|
| Research Design | 1 | 2009 | 716 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2015 | 223 | 0.050 |
Why?
|
| Creatine Kinase | 2 | 2001 | 61 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 555 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 2004 | 95 | 0.050 |
Why?
|
| Granulosa Cells | 1 | 2004 | 143 | 0.050 |
Why?
|
| Male | 11 | 2010 | 64957 | 0.050 |
Why?
|
| Mice | 7 | 2014 | 18301 | 0.050 |
Why?
|
| Isoenzymes | 2 | 2001 | 211 | 0.050 |
Why?
|
| Obesity | 1 | 2015 | 2426 | 0.050 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2003 | 61 | 0.050 |
Why?
|
| Signal Transduction | 5 | 2014 | 4686 | 0.050 |
Why?
|
| Chromosomes, Human, Y | 1 | 2003 | 52 | 0.050 |
Why?
|
| Paclitaxel | 1 | 2023 | 130 | 0.050 |
Why?
|
| ROC Curve | 5 | 2004 | 613 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 533 | 0.050 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 2323 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 1591 | 0.050 |
Why?
|
| Dydrogesterone | 1 | 2022 | 1 | 0.050 |
Why?
|
| Cellular Senescence | 2 | 2002 | 217 | 0.050 |
Why?
|
| Chromosomes, Human, X | 1 | 2003 | 155 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2002 | 34 | 0.050 |
Why?
|
| Splenic Artery | 1 | 2002 | 22 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2009 | 1559 | 0.050 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2002 | 63 | 0.050 |
Why?
|
| Cyclophosphamide | 1 | 2023 | 428 | 0.040 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2001 | 55 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2003 | 363 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2002 | 172 | 0.040 |
Why?
|
| Infertility, Male | 1 | 2004 | 296 | 0.040 |
Why?
|
| Animals | 8 | 2014 | 33912 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 2 | 2017 | 451 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2023 | 17753 | 0.040 |
Why?
|
| Attention | 1 | 2022 | 194 | 0.040 |
Why?
|
| Cell Separation | 1 | 2001 | 218 | 0.040 |
Why?
|
| Rh Isoimmunization | 1 | 2000 | 27 | 0.040 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2000 | 63 | 0.040 |
Why?
|
| Algorithms | 3 | 1999 | 1680 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2003 | 1211 | 0.040 |
Why?
|
| Pregnancy Outcome | 2 | 2004 | 623 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2006 | 1106 | 0.040 |
Why?
|
| Prevalence | 1 | 2006 | 2701 | 0.040 |
Why?
|
| Risk Factors | 5 | 2007 | 11074 | 0.040 |
Why?
|
| Middle Cerebral Artery | 1 | 2000 | 118 | 0.040 |
Why?
|
| Humerus | 1 | 1998 | 16 | 0.040 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 1999 | 14 | 0.040 |
Why?
|
| DNA | 1 | 2004 | 1399 | 0.040 |
Why?
|
| False Positive Reactions | 4 | 2000 | 143 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2885 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2012 | 1013 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2001 | 556 | 0.040 |
Why?
|
| Fetofetal Transfusion | 1 | 2001 | 206 | 0.040 |
Why?
|
| Umbilical Arteries | 1 | 1999 | 100 | 0.040 |
Why?
|
| Cerebral Arteries | 1 | 1999 | 81 | 0.040 |
Why?
|
| Chorionic Gonadotropin | 1 | 1998 | 76 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 4 | 1999 | 162 | 0.030 |
Why?
|
| Sensitivity and Specificity | 5 | 2002 | 2085 | 0.030 |
Why?
|
| Spleen | 1 | 1999 | 258 | 0.030 |
Why?
|
| Fetal Blood | 1 | 1999 | 176 | 0.030 |
Why?
|
| Arteries | 1 | 1999 | 208 | 0.030 |
Why?
|
| Transcriptome | 2 | 2015 | 1103 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2013 | 4738 | 0.030 |
Why?
|
| Immunization | 1 | 1999 | 269 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 1999 | 253 | 0.030 |
Why?
|
| Fetal Diseases | 1 | 2000 | 440 | 0.030 |
Why?
|
| Sperm Motility | 2 | 2009 | 113 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 378 | 0.030 |
Why?
|
| Pre-Eclampsia | 1 | 1998 | 226 | 0.030 |
Why?
|
| Genome, Human | 2 | 2015 | 1321 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2014 | 3819 | 0.030 |
Why?
|
| Time Factors | 2 | 2004 | 6196 | 0.030 |
Why?
|
| Incidence | 1 | 2003 | 3360 | 0.030 |
Why?
|
| Middle Aged | 5 | 2023 | 28601 | 0.030 |
Why?
|
| Fos-Related Antigen-2 | 1 | 2015 | 4 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2015 | 20 | 0.030 |
Why?
|
| Immunoassay | 1 | 2015 | 126 | 0.030 |
Why?
|
| Nucleotide Motifs | 1 | 2015 | 51 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 1998 | 687 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2015 | 99 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2015 | 110 | 0.030 |
Why?
|
| Amniocentesis | 3 | 1999 | 77 | 0.030 |
Why?
|
| Receptor, ErbB-3 | 1 | 2014 | 24 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2014 | 37 | 0.030 |
Why?
|
| Wnt4 Protein | 1 | 2014 | 23 | 0.030 |
Why?
|
| Maternal Age | 3 | 1999 | 136 | 0.030 |
Why?
|
| Cell Movement | 1 | 2017 | 876 | 0.030 |
Why?
|
| Activins | 1 | 2013 | 72 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2013 | 37 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2014 | 356 | 0.020 |
Why?
|
| Reference Values | 3 | 1999 | 676 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 491 | 0.020 |
Why?
|
| Phenotype | 1 | 2022 | 4497 | 0.020 |
Why?
|
| Choristoma | 1 | 2012 | 43 | 0.020 |
Why?
|
| Predictive Value of Tests | 3 | 2004 | 2304 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2012 | 276 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2012 | 86 | 0.020 |
Why?
|
| Binding Sites | 1 | 2015 | 1133 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2011 | 3359 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 407 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 135 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 224 | 0.020 |
Why?
|
| Cytokines | 1 | 2017 | 1339 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 588 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 423 | 0.020 |
Why?
|
| Protein Binding | 1 | 2015 | 1652 | 0.020 |
Why?
|
| Base Sequence | 1 | 2015 | 2730 | 0.020 |
Why?
|
| United States | 1 | 2006 | 12072 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2012 | 254 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 3829 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3464 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 619 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 639 | 0.020 |
Why?
|
| Software | 1 | 2015 | 733 | 0.020 |
Why?
|
| Morbidity | 2 | 2001 | 256 | 0.020 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 1990 | 135 | 0.020 |
Why?
|
| Desmin | 1 | 2009 | 19 | 0.020 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2009 | 32 | 0.020 |
Why?
|
| Caveolin 1 | 1 | 2009 | 51 | 0.020 |
Why?
|
| Cytological Techniques | 1 | 2009 | 18 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2009 | 54 | 0.020 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2009 | 52 | 0.020 |
Why?
|
| Receptors, Peptide | 1 | 2009 | 60 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 2825 | 0.020 |
Why?
|
| Quality Control | 1 | 2009 | 116 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 287 | 0.020 |
Why?
|
| Pacemaker, Artificial | 1 | 1990 | 193 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 2904 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2007 | 2406 | 0.020 |
Why?
|
| Mice, Inbred AKR | 1 | 2007 | 15 | 0.020 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2007 | 28 | 0.020 |
Why?
|
| Heart Rate | 1 | 1990 | 577 | 0.020 |
Why?
|
| High Mobility Group Proteins | 1 | 2007 | 33 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 2550 | 0.020 |
Why?
|
| Threonine | 1 | 2007 | 62 | 0.020 |
Why?
|
| Forecasting | 2 | 1999 | 351 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2007 | 154 | 0.020 |
Why?
|
| SOX9 Transcription Factor | 1 | 2007 | 82 | 0.020 |
Why?
|
| Alanine | 1 | 2007 | 160 | 0.020 |
Why?
|
| Introns | 1 | 2007 | 278 | 0.020 |
Why?
|
| Prospective Studies | 4 | 1999 | 6459 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 5196 | 0.010 |
Why?
|
| Andrology | 1 | 2005 | 3 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 1447 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 405 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2011 | 889 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2007 | 729 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2009 | 1571 | 0.010 |
Why?
|
| Fetus | 2 | 1999 | 568 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1990 | 970 | 0.010 |
Why?
|
| Hyaluronan Synthases | 1 | 2004 | 13 | 0.010 |
Why?
|
| Serum Amyloid P-Component | 1 | 2004 | 14 | 0.010 |
Why?
|
| Infant, Newborn | 3 | 2004 | 8635 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 63 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2009 | 760 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2005 | 808 | 0.010 |
Why?
|
| Ovulation Induction | 1 | 2004 | 38 | 0.010 |
Why?
|
| Glucuronosyltransferase | 1 | 2004 | 63 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 121 | 0.010 |
Why?
|
| Logistic Models | 2 | 1999 | 1797 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 3370 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 1211 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2002 | 191 | 0.010 |
Why?
|
| Adolescent | 2 | 2013 | 20987 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2004 | 450 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2002 | 238 | 0.010 |
Why?
|
| Amnion | 1 | 2001 | 42 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 3748 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2002 | 417 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2009 | 1939 | 0.010 |
Why?
|
| Cordocentesis | 1 | 2000 | 11 | 0.010 |
Why?
|
| International Cooperation | 1 | 2001 | 165 | 0.010 |
Why?
|
| Wound Healing | 1 | 2004 | 490 | 0.010 |
Why?
|
| Amniotic Fluid | 1 | 2001 | 147 | 0.010 |
Why?
|
| Heart Rate, Fetal | 1 | 2000 | 62 | 0.010 |
Why?
|
| Drainage | 1 | 2001 | 250 | 0.010 |
Why?
|
| Image Cytometry | 1 | 1999 | 18 | 0.010 |
Why?
|
| Ultrasonics | 1 | 1999 | 31 | 0.010 |
Why?
|
| Rheology | 1 | 1999 | 24 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2004 | 541 | 0.010 |
Why?
|
| Pulsatile Flow | 1 | 1999 | 110 | 0.010 |
Why?
|
| Karyotyping | 1 | 1999 | 308 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1998 | 148 | 0.010 |
Why?
|
| Biometry | 1 | 1998 | 101 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2001 | 1483 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1999 | 286 | 0.010 |
Why?
|
| Birth Weight | 1 | 1999 | 347 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2004 | 1590 | 0.010 |
Why?
|
| Creatinine | 1 | 1998 | 398 | 0.010 |
Why?
|
| Aged | 2 | 2009 | 21025 | 0.010 |
Why?
|
| Registries | 1 | 2001 | 1634 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2002 | 5063 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1990 | 63 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1990 | 149 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1990 | 294 | 0.000 |
Why?
|
| Epinephrine | 1 | 1990 | 150 | 0.000 |
Why?
|
| Exercise Test | 1 | 1990 | 239 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1990 | 1626 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2002 | 12936 | 0.000 |
Why?
|